Q4 2014 13F Holders as of 31 Dec 2014
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
114,331,829
-
Total 13F shares
-
10,275,305
-
Share change
-
+3,146
-
Total reported value
-
$51,680,000
-
Price per share
-
$5.02
-
Number of holders
-
23
-
Value change
-
-$3,435
-
Number of buys
-
13
-
Number of sells
-
6
Institutional Holders of FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share (FATE) as of Q4 2014
As of 31 Dec 2014,
FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share (FATE) was held by
23 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
10,275,305 shares.
The largest 10 holders included
FMR LLC, Polaris Venture Management Co. V, L.L.C., KINGDON CAPITAL MANAGEMENT, L.L.C., WELLINGTON MANAGEMENT GROUP LLP, ORBIMED ADVISORS LLC, Board of Trustees of The Leland Stanford Junior University, PRINCIPAL FINANCIAL GROUP INC, VANGUARD GROUP INC, Alyeska Investment Group, L.P., and GOLDMAN SACHS GROUP INC.
This page lists
23
institutional shareholders reporting positions in this security
for the Q4 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.